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Intestinal dendritic cells (DC) maintain a balance between
tolerance of nutrients/commensals and immunity against
pathogens. Here, we report lower numbers of
CD103þSIRPaþ DC, with a more mature phenotype and
higher immune activity, in the proximal than in the distal
healthy human colon.
BACKGROUND & AIMS: Most knowledge about gastrointes-
tinal (GI)-tract dendritic cells (DC) relies on murine studies
where CD103þ DC specialize in generating immune tolerance
with the functionality of CD11bþ/ subsets being unclear. In-
formation about human GI-DC is scarce, especially regarding
regional speciﬁcations. Here, we characterized human DC
properties throughout the human colon.
METHODS: Paired proximal (right/ascending) and distal
(left/descending) human colonic biopsies from 95 healthy
subjects were taken; DC were assessed by ﬂow cytometry and
microbiota composition assessed by 16S rRNA gene
sequencing.
RESULTS: Colonic DC identiﬁed were myeloid (mDC,
CD11cþCD123) and further divided based on CD103 and
SIRPa (human analog of murine CD11b) expression.CD103-SIRPaþ DC were the major population and with
CD103þSIRPaþ DC were CD1cþILT3þCCR2þ (although CCR2
was not expressed on all CD103þSIRPaþ DC). CD103þSIRPa-
DC constituted a minor subset that were CD141þILT3CCR2.
Proximal colon samples had higher total DC counts and fewer
CD103þSIRPaþ cells. Proximal colon DC were more mature
than distal DC with higher stimulatory capacity for
CD4þCD45RAþ T-cells. However, DC and DC-invoked T-cell
expression of mucosal homing markers (b7, CCR9) was lower
for proximal DC. CCR2 was expressed on circulating CD1cþ, but
not CD141þ mDC, and mediated DC recruitment by colonic
culture supernatants in transwell assays. Proximal colon DC
produced higher levels of cytokines. Mucosal microbiota
proﬁling showed a lower microbiota load in the proximal colon,
but with no differences in microbiota composition between
compartments.
CONCLUSIONS: Proximal colonic DC subsets differ from those
in distal colon and are more mature. Targeted immunotherapy
using DC in T-cell mediated GI tract inﬂammation may there-
fore need to reﬂect this immune compartmentalization. (Cell
Mol Gastroenterol Hepatol 2016;2:22–39; http://dx.doi.org/
10.1016/j.jcmgh.2015.08.006)Keywords: CCR2; Dendritic Cells; Distal Colon; Human Gastro-
intestinal Tract; Proximal Colon; Microbiota.
CCR2 and Human Colonic DC 23Dendritic cells (DC), unique in their ability togenerate primary T-cell-mediated immune re-
January 2016sponses and potent promoters of secondary activity, dictate
whether immune responses are immunogenic or tolerogenic
and determine their tissue speciﬁcity.1 In the gastrointes-
tinal (GI) tract, DC maintain a balance between tolerance to
nutrients and/or commensal microorganisms (the micro-
biota) and immunity against pathogens.2–4
Human myeloid DC (mDC; CD11cþ) can be divided into
CD1cþ (analogous to mouse CD11bþ specialized for classic
presentation) and CD141þ (analogous to mouse CD8aþ
specialized for cross presentation).5 Most current knowledge
about GI tract DC comes from mice, and typically from the
small intestine, where CD103þ DC specialize in generating
regulatory T-cell (Treg) responses critical for prevention of
spontaneous inﬂammation. Some of these properties appear
to be maintained in the human GI tract.6–8 Further charac-
terization of murine CD103þ DC revealed that the subset
coexpressing CD11bþ is unique to the GI tract, with the
CD103þSIRPaþ (CD103þ/signal regulatory protein aþ) DC
subset representing their human counterpart.9 CD103þ DC as
a whole are regulatory, but it is unclear whether speciﬁc
subsets perform distinct functions because CD103þCD11bþ
DC can control immune tolerance (via retinaldehyde dehy-
drogenase type 2 (RALDH2) and retinoic acid production),9–13
but can also induce helper T-cell 17 (TH17) responses;
14 this
latter property suggests some bystander effect and/or
redundancy between subsets. CD103 DC can also generate
retinoic acid and migrate to lymph nodes.15 Although murine
studies further our understanding of GI tract DC immunology,
they may not always be relevant to humans;16,17 for example,
RALDH2 activity is not restricted toDC in the human colon but
is also expressed in macrophages.18
Discrepancies between human and murine DC may
reﬂect environmental and tissue differences as most murine
studies focus on the small bowel and human studies are
usually of the lower GI tract. There is therefore a need to
study human intestinal DC in the context of different
anatomic locations as murine DC subsets and function vary*Current address: Gastroenterology Unit, Hospital Universitario de La
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http://dx.doi.org/10.1016/j.jcmgh.2015.08.006throughout the GI tract.10,19,20 In agreement with this
notion, we have recently showed that human large (colon)
and small bowel (terminal ileum) DC have different prop-
erties, with a lower proportion of DC producing proin-
ﬂammatory cytokines in the human colon compared with
the (paired) ileum, coupled with a higher capacity of colonic
DC to generate Treg cells.21 Moreover, colonic and ileal DC
have differential abilities to imprint homing properties on
the T cells they stimulate, suggesting DC compartmentali-
zation through the human GI tract.21 These regional differ-
ences in human GI tract DC are in agreement with other
observations,9 which together suggest the presence of
regional immune specialization in the GI tract.22
To further explore the possibility that DC change through
the GI tract we focused on the human colon, which is struc-
tured into different areas. After the terminal ileum (small
bowel), the colon starts at the cecum, followed by the right or
ascending colon, transverse colon, descending colon, sigmoid
colon, and ﬁnally the rectum. The right (ascending or proximal
side) and left (descending or distal side) part of the human
colon have different physiology, embryologic origins, gene
expression and epigenetic proﬁles, microbiota load, and
microbiota metabolic activities.23–26 Moreover, proximal and
distal colorectal cancers are recognized as different entities,
with proximal colorectal cancer having a lower prevalence but
aworse prognosis.27 Therefore, DCpropertiesmay not only be
different between the small and the large bowel,21 but also
between different areas of the colon. Our hypothesis is that in
DC subsets, their phenotype and function change through the
human GI tract and that DC from different colonic compart-
ments have different immunologic properties.Material and Methods
Biological Samples
Colonic biopsies were obtained at colonoscopy from a
total of 95 healthy controls (44.9% males; 57.9 ± 12.9 years
(mean ± standard deviation); age interval 28–81). All
samples were obtained after bowel preparation for colo-
noscopy, which can have an impact on mucosa-associated
microbiota composition.28,29 Samples were obtained in all
cases after informed consent and ethics approval from the
Hospital Clínico Universitario de Valladolid (Spain) or the
Outer West London Research Ethics Committee (United
Kingdom). The patients had been referred for colorectal
cancer screening or for rectal bleeding or changes in bowel
transit. In all cases they had macroscopically and histolog-
ically normal intestines. Proximal colon refers to the right or
ascending colon (closer to the small intestine); distal colon
refers to the left or descending colon (closer to the rectum).
Paired biopsies from both the distal and proximal colon
were collected (maximum of ﬁve biopsies from each area) in
ice-chilled complete medium (Dutch modiﬁed RPMI
1640 (Sigma-Aldrich, Dorset, United Kingdom) containing
100 mg/mL penicillin/streptomycin, 2 mM L-glutamine, 50
mg/mL gentamicin (Sigma-Aldrich), and 10% fetal calf
serum (TCS Cellworks, Buckingham, United Kingdom)), and
they were processed within 1 hour. Gender did not affect
the expression of any of the studied parameters. Age,
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with mRNA expression of e-cadherin (Pearson’s r: 0.66,
P ¼ .035) and microbiota load as determined by quantifying
16S rRNA (Pearson’s r: 0.75, P ¼ .011).
Human peripheral blood was collected from healthy
volunteers with no known autoimmune or inﬂammatory
diseases, allergies, or malignancies after informed consent
had been obtained. Peripheral blood mononuclear cells
(PBMC) were obtained by centrifugation over Ficoll-Paque
PLUS (Amersham Biosciences, Chalfont St. Giles, United
Kingdom). Some PBMC were washed twice in phosphate-
buffered saline containing 1 mM EDTA and 0.02% sodium
azide (ﬂuorescence-activated cell sorting [FACS] buffer) and
stained with ﬂuorochrome-conjugated antibodies; others
were used to enrich naive T cells.
Lamina Propria Dendritic Cells
Lamina propria DC were characterized by ﬂow cytom-
etry as previously described elsewhere.21,30–32 Brieﬂy,
freshly obtained biopsies were incubated with Hank’s
balanced salt solution (GIBCO BRL, Paisley, Scotland, United
Kingdom) containing 1 mM dithiothreitol for 20 minutes
and then in 1 mM EDTA solutions to remove the associated
mucus/bacteria and epithelial layer, respectively. Lamina
propria mononuclear cells (LPMC) were obtained from bi-
opsy tissue after quick collagenase digestion with 1 mg/mL
of collagenase D (Roche Diagnostics, Lewes, United
Kingdom). LPMC were collected by centrifugation, washed
twice in FACS buffer, and stained with ﬂuorochrome-
conjugated antibodies. Viable DC were identiﬁed by ﬂow
cytometrywithin single live cells as CD45þHLA-DRþ lineage
(CD3 CD14 CD16 CD19 CD34) based on Forward and Side
scatter characteristics (Figure 1A).
In some cases, LPMC were cultured overnight (37C, 5%
CO2, high humidity) and subsequently enriched for DC after
density-gradient centrifugation (600g, 15 minutes at room
temperature) using NycoPrep (Progen Biotechnik, Heidel-
berg, Germany), and were then cultured with T cells. The cells
collected from the interface (typically 25,000–50,000 cells)
have been characterized as functional colonic DC.17,21,30–34
Antibody Labeling
LPMC and/or PBMC were stained with monoclonal anti-
bodies for DC characterization. Supplementary Table 1
shows the speciﬁcity, clone ﬂuorochrome, and sources of
the antibodies used. Cells were labeled in FACS buffer.
Labeling was performed on ice and in the dark for 20 mi-
nutes. Cells were washed twice in FACS buffer, ﬁxed with 1%
paraformaldehyde in 0.85% saline, and stored at 4C before
acquisition on the ﬂow cytometer (within 48 hours).
Appropriate isotype-matched control antibodies were pur-
chased from the same suppliers. For intracellular staining,
cells were ﬁxed with Leucoperm A (AbD Serotec, Kidlington,
United Kingdom) after surface staining and permeabilized
with Leucoperm B (AbD Serotec) before intracellular
staining.
Endocytic activity of DCs was determined by uptake of
ﬂuorescein isothiocyanate (FITC)-dextran (molecular mass40 kDa) (100 mg/mL; Sigma-Aldrich), 30 minutes at 37C or
on ice (internal control).21,33 The surface staining for ﬂow
cytometry acquisition was subsequently performed as
described here.
Proliferation Assays
CD4þ naïve T-cells were obtained from freshly isolated
PBMC, suspended in MiniMACs buffer (phosphate-buffered
saline containing 0.5% bovine serum albumin and 2 mM
EDTA) and depleted of CD14, CD19, CD8, CD45RO, and HLA-
DR positive cells with immunomagnetic beads (Miltenyi
Biotech, Bisley, United Kingdom) following the manufac-
turer’s instructions. CD4þ naive T-cells were labeled with
10 mM 5-carboxy ﬂuorescein diacetate succinimidyl ester
(CFSE) (Invitrogen/Life Technologies, Paisley, United
Kingdom) and cultured (4  105/well) for 5 days in
U-bottomed 96-well microtiter plates (BD Biosciences,
Oxford, United Kingdom) with 0, 1%, 2%, or 3% enriched
allogeneic colonic DC. Cells were recovered, and CFSElow
proliferating cells were identiﬁed, quantiﬁed, and pheno-
typed by ﬂow cytometry.
Culture Supernatants
Freshly obtained intestinal biopsy samples were imme-
diately cultured in complete medium (1 biopsy per 1 mL of
complete medium per well) for 24 hours, after which cul-
ture media were ﬁltered (0.45 mm) and cell-free superna-
tants preserved (80C) until they were analyzed using a
FlowCytomix Multiple Analyte Detection (eBioscience, Wien,
Austria) on a BD CantoII ﬂow cytometer (BD Biosciences),
following the manufacturer’s instructions, for the concen-
tration of interferon (IFN) g (detection limit [DL]: 0.25
pg/mL), IFNa (DL: 4.04 pg/mL), interleukin-1b (IL-1b)
(DL: 1.80 pg/mL), IL-2 (DL: 0.35 pg/mL), IL-4 (DL: 1.22
pg/mL), IL-5 (DL: 0.76 pg/mL), IL-6 (DL: 4.10 pg/mL), IL-7
(DL: 3.18 pg/mL), IL-9 (DL: 1.17 pg/mL), IL-10 (DL: 2.88
pg/mL), IL-12p70 (DL: pg/mL), IL-13 (DL: 0.43 pg/mL),
IL-17A (DL: 0.89 pg/mL), IL-22 (DL: 3.98 pg/mL), IL-23
(DL: 29.14 pg/mL), IL-27 (DL: 0.79 pg/mL), leptin
(DL: 34.95 pg/mL), and tumour necrosis factor-a (DL: 3.10
pg/mL). IgA content was determined via radial immuno-
diffusion kit (DL: 8.5 mg/L; Kit IgA RID-ML, Binding Site
Group, Birmingham, United Kingdom) following the manu-
facturer’s instructions. Values below the level of detection
were reported as equal to it.
Quantitative Reverse-Transcription Polymerase
Chain Reaction
Freshly obtained intestinal biopsies were immediately
embedded in RNAlater (Ambion/Life Technologies, Paisley,
United Kingdom) and snap-frozen (80C). Total RNA was
isolated from each biopsy using the TRIzol reagent accord-
ing to the protocol provided by the manufacturer. Reverse
transcription was performed by using the SuperScript First-
Strand Synthesis System for Reverse-Transcriptase-PCR Kit
(Invitrogen/Life Technologies) using random hexamers. The
mRNA levels of RALDH2, CCL25, MADCAM1, e-cadherin, and
GADPH (housekeeping gene) were measured by real-time
Figure 1. Identiﬁcation of human colonic dendritic cells (DC). (A) Total antigen-presenting cells (CD45þHLA-DRhigh) were
identiﬁed within single viable cells (based on the forward/side scatter properties). DC were further discriminated from mac-
rophages (M4) based on lineage marker expression (CD3, CD14, CD16, CD19, CD34). (B) In contrast to putative macrophages
(CD45þHLA-DRþlineageþ), DC (CD45þHLA-DRþlineage) were CD64CD14 and up-regulated CCR7 expression after
overnight culture (blue histogram) as well as (C) CD40 and CD86, compared with fresh noncultured cells (red histogram).
Shaded histogram in B and C denotes isotypes. (D) Percentages of DC within the total number of single lamina propria
mononuclear cells (LPMC) were higher in the proximal (Prox) colon compared with the distal (Dist) (n ¼ 43). (E) Lamina propria
DC were mainly CD11cþ myeloid DC (mDC). Lack of non-mDC in the human colon was unlikely to be due to sample pro-
cessing, as distribution of CD11cþ and CD123þ blood DC was not altered after dithiothreitol þ EDTA þ collagenase incubation
(gut-protocol) of peripheral blood mononuclear cells. (F) Most human colonic DC were CD1cþ, in contrast to CD141þDC, with
no differences between the proximal and distal colon. Data shown in B, C, and E are representative of two independent
experiments. Paired t tests were applied in D and F. P < .05 was considered statistically signiﬁcant (****P < .0001).
January 2016 CCR2 and Human Colonic DC 25polymerase chain reaction (PCR) by using a LightCycler
instrument (Roche Applied Science, Mannheim, Germany).
Microbiota load was determined via 16S rRNA ampliﬁcation.
Reactions were performed using the FastStart SYBR Green
MasterMix (Roche Diagnostics) with thermolabile uracil
DNA glycosylase (Roche Diagnostics) to prevent carryover
contamination. Primer sets and PCR conditions are
described in Supplementary Table 2. Levels are expressed
as the ratio molecule/GADPH in arbitrary units (U).Migration Experiments
We placed 1 million fresh PBMC in the upper insert of
transwell culture plates, and their capacity to migrate
through 3 mm pores was assessed by ﬂow cytometry aftercollection of the cells in the lower chamber. Colonic biopsy
tissues from the proximal and distal colon were cultured as
above in 24-well culture plates (three biopsy samples per
well in 1.5 mL of complete medium) for 18 hours, after
which the samples were ﬁltered (0.45 mm) and the cell-free
culture supernatants used immediately in the lower cham-
ber of transwell culture plates (Sigma-Aldrich).
In some experiments, the colonic supernatants were
incubated (20 minutes, room temperature) with anti-
chemokine (C-C motif) ligand 2 (anti-CCL2, 1 mg/mL)
before performing the migration experiments. In other
cases, the lower chamber contained fresh complete medium
supplemented with different doses of human recombinant
CCL2. The addition of ﬂuorescent counting beads (Flow-
count Fluorospheres; Beckman Coulter, Brea, CA) before
Figure 1. (continued).
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absolute number of migrated cells into the lower chamber.
The results are shown as a ratio compared with the basal or
spontaneous migration.
Flow Cytometry and Data Analysis
Cells were acquired on a BD Canto II (BD Biosciences) or
a LSR Fortessa ﬂow cytometer (BD Biosciences) and
analyzed using WinList 3D 7.1 software (Verity Software
House, Topsham, ME). The proportion of cells positive for a
given marker was determined by reference to staining with
an isotype-matched control antibody.
Electron Microscopy
Electron microscopy characterization of colonic DC was
performed as previously described elsewhere.21,33,35 Brieﬂy,
between 200,000 and 1,000,000 LPMC were ﬁxed in 3%
glutaraldehyde in 0.1 M sodium phosphate buffer (SPB), pH
7.4, for up to 2 hours at room temperature and then were
maintained at 4C until they were processed. The cells were
washed in the 0.1 M SPB (pH 7.4) and embedded as a pelletin low-gelling-temperature agarose (Sigma-Aldrich). They
were washed in 0.1 M SPB (pH 7.4) and postﬁxed in 1%
osmium tetroxide in 0.1% SPB (pH 7.4) for 1 hour. The
samples were then washed and left in distilled water
overnight to remove the phosphate and were block stained
in 2% uranyl acetate for 2 to 4 hours. The samples were
washed with dH2O and dehydrated using an acetone
gradient and gradually inﬁltrated with Araldite resin. The
Araldite was changed twice over 4 to 8 hours, and the
samples were embedded in the Araldite resin and then
cured for 18 hours at 65C.
Ultrathin sections (100 nm thick) were cut on a Reichert-
Jung Ultracut E microtome (Leica, Wetzlar, Germany) and
collected on a 200 mesh copper grid. After staining with
Reynold’s lead citrate, the grid was carbon coated and
visualized using a JEOL 1200 EX electron microscope (JEOL,
Tokyo, Japan).
The DC were identiﬁed as previously described else-
where.33–36 The DC were subsequently classiﬁed into
mature and immature DC based on their morphology by
electron microscopy. Immature DC were small cells with
short veils relative to their size, a small area of cytoplasm,
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surrounding the nucleus and chromatic dense clusters
within the nucleus. In contrast, mature DC had long veiled
projections.21
Microbiota Analysis
Paired biopsy samples from the proximal and distal
colon were collected from a total of 19 healthy controls
(9 women, 10 men; mean age: 59.7 ± 10.2 years) with no
known autoimmune disease and/or malignancies. The bi-
opsy tissues were immediately embedded in RNAlater
(Ambion) and snap-frozen at 80C. DNA was extracted
using the FastDNA SPIN Kit for Soil in conjunction with a
Fastprep-24 machine (MP Biomedicals, Santa Ana, CA)
following the manufacturer’s protocols.
The V1–V2 regions of bacterial 16S rRNA genes were PCR
ampliﬁed using Q5 Taq polymerase (New England BioLabs,
Ipswich, MA) and Golay barcoded primers (purchased from
Euroﬁns MWG Operon, Huntsville, AL) MiSeq-27F (50-AAT
GATACGGCGACCACCGAGATCTACACTATGGTAATT CCAGMG
TTYGATYMTGGCTCAG-30) and MiSeq-338R (50-CAAGCAGAA
GACGGCATACGAGAT-barcode-AGTCAGTCAGAAGCTGCCTCCC
GTAGGAGT-30). Each sample included in the study was
ampliﬁed with a 338R primer containing a unique 12-mer
Golay barcode sequence. The PCR conditions were as fol-
lows: 98C for 2 minutes followed by 25 cycles of 98C for 30
seconds, 50C for 30 seconds, 72C for 1 minute and 30
seconds, and then a ﬁnal extension step at 72C for 5 mi-
nutes. Four PCR reactions per sample were performed, which
were then pooled into a single amplicon mix for each of the
samples. The PCR amplicons from each sample were then
quantiﬁed using a Qubit 2.0 Fluorometer (Invitrogen/Life
Technologies), and equimolar concentrations of each sample
were added together into a ﬁnal mastermix for sequencing
on an Illumina MiSeq machine (2  250 bp read length)
(Illumina, San Diego, CA).
Sequence data have been deposited in the European
Nucleotide Archive (http://www.ebi.ac.uk/ena) under study
number ERP007146. The individual accession numbers for
each of the biopsy samples are shown in Supplementary
Table 3.
The resulting sequence data was processed using the
mothur software package (http://www.mothur.org/),
closely following their MiSeq SOP.37 In brief, paired contigs
were created from the forward and reverse MiSeq reads,
and all contigs shorter than 260 bp (base pairs) and longer
than 450 bp, and those containing any ambiguous bases or
homopolymeric stretches of longer than seven bases
were removed. Chimeras were removed using Perseus38 as
implemented in mothur. Operational taxonomic units
(OTUs) were generated from preclustered data (diffs ¼ 3) at
the 97% cutoff level and then assigned a taxonomic classi-
ﬁcation using the Ribosomal Database Project (RDP) tax-
onomy provided with mothur. Diversity measures such as
Shannon and inverse Simpson indices were calculated in
mothur, where every sample was ﬁrst subsampled down to
450 reads to ensure equal sequencing depth for these
comparisons. Good’s coverage (an estimate of completeness
of species sampling) at this sequencing depth was onaverage 93.4%. A cluster dendrogram using the Bray Curtis
calculator was generated in mothur and visualized using the
iTOL online resource (http://itol.embl.de/).39 Differences in
bacterial community structure between proximal and distal
colonic biopsies were assessed using the analysis of
molecular variance (AMOVA), parsimony, Metastats,40 and
LEfSe41 tests as implemented in the mothur software
package.
Statistical Analyses
Two-tailed paired t test, two-tailed Pearson’s correlation,
and two-way paired analysis of variance (ANOVA) were
applied as explained in each section/ﬁgure legend. In the
case of multiple comparisons, subsequent ad hoc Bonferroni
correction was applied. Microbiota data were compared
using the AMOVA, parsimony, Metastats,40 and LEfSe41 tests
as implemented in the mothur software package.42 P < .05
was considered statistically signiﬁcant.
Results
Identiﬁcation of Human Colonic Dendritic Cells
Antigen-presenting cells (CD45þHLA-DRhigh) were iden-
tiﬁed within LPMC. DC discrimination from macrophages
(M4) and B cells was based on lack of expression of markers
of other lineages (Figure 1A), as we and others have pre-
viously described.17,18,21,31,32,34 DC also had lower granu-
larity as they lack M4 vacuolar systems, aiding discrimination
between DC and M4. Further analysis conﬁrmed that DC
gated in this way were CD14 and CD64 (see Figure 1B).
Additionally, in contrast to M4, DC up-regulated chemokine
(C-C motif) receptor 7 (CCR7) expression after 18 hours of
culture (Figure 1B).18 Culture also induced DC maturation
(see Figure 1C), and these DC were used in functional ex-
periments for T-cell stimulatory capacity,21,31,33 avoiding
the need for additional exogenous stimulation.
The DC numbers were statistically signiﬁcantly higher in
the proximal colon (see Figure 1D), with all DC in both
compartments being mDC (CD11cþCD123-) (see Figure 1E).
The inability to detect non-mDC in human colonic biopsies
was not due to sample processing and/or collagenase
digestion as this protocol was able to detect plasmacytoid
dendritic cells (pDC) in PBMC samples processed in parallel
with colonic biopsy tissues (see Figure 1E). This is in
agreement with recent observations suggesting that non-
mDC in the human GI tract are scarce or absent.18,43
Further analysis of colonic mDC conﬁrmed that most were
CD1cþ DC and not CD141þ DC (see Figure 1F), with no
differences between compartments.
Dendritic Cell Subsets in the Human Colon
Comparisons of DC subsets derived from the proximal
and distal human colon were made based on CD103 and
SIRPa expression9,21 (Figure 2A). SIRPaþ DC were equally
distributed in each compartment, but there was a lower
proportion of CD103þ DC in the proximal colon biopsy
samples (see Figure 2B), which translated into lower
numbers of CD103þSIRPaþ DC (analogous to murine
CD103þCD11bþ DC)9 at this site (see Figure 2C). Further
Figure 2. Dendritic cell (DC) subsets in the human colon. (A) DC were identiﬁed (as in Figure 1A) and were divided into
subsets based on expression of CD103 and SIRPa. (B, C) Relative proportions of DC in subsets in the proximal (Prox) and
distal (Dist) human colon. (D) CD103SIRPaþ, CD103þSIRPaþ, and CD103þSIRPa DC were characterized for CD1c and
CD141; and also for (E) CX3CR1, ILT3, CD40, and b7. (F) SIRPaþCD103 and SIRPaþCD103þ DC subsets were identiﬁed (as
in A), and b7 and CD40 expression was studied in biopsy samples from the proximal (blue) and distal (red) human colon
compared with the isotype (shaded histogram). Results from D and E are from at least ﬁve independent experiments; results
from F are representative of three independent experiments. Paired t test (B and C) and paired one-way analysis of variance
with Bonferroni’s ad-hoc analysis (D, E) were applied. P < .05 was considered statistically signiﬁcant (**P < .01; ***P < .001;
****P < .0001).
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January 2016 CCR2 and Human Colonic DC 29characterization revealed that SIRPaþ DC (both CD103þ and
CD103) were typically CD1cþ whereas CD103þSIRPa
were CD141þ DC (see Figure 2D).9,10 CX3CR1 was virtually
absent in all colonic DC (see Figure 2E) but was expressedby macrophages,17 whereas the GI-tract homing b7 integrin
was expressed by the majority of colonic DC, with all
CD103þ DC being positive. SIRPa, which regulates homeo-
static properties of intestinal DC,44 was typically
Figure 3. Chemokine (C-C motif) receptor 2 (CCR2) mediates blood dendritic recruitment by the human colon.
(A) CD103SIRPaþ, CD103þSIRPaþ, and CD103þSIRPa dendritic cells (DC) were identiﬁed (as in Figure 2A) and assessed
for the expression of CCR2. (B) Pooled data of CCR2 expression on different subsets and in the proximal and distal colon.
(C) Peripheral blood mononuclear cells (PBMC) studied by ﬂow cytometry. After exclusion of CD19, CD14, and CD16, DC were
identiﬁed within HLA-DRþ as plasmacytoid (pDC, CD123þ) or myeloid (mDC, CD11cþ). The mDC were further divided into
CD1cþ and CD141þ. (D) Expression of SIRPa, ILT3, and CCR2 was determined on peripheral CD1cþ mDC, and CD141þ mDC
and pDC. (E) After 1 million PBMC were placed in the upper insert of a transwell chamber, their migration toward different
concentrations of CCL2 was determined 3 hours later. Total migrated CD11cþHLA-DRþ cells were identiﬁed by ﬂow cytometry
and further divided into monocytes (CD14þlineageþ) and DC (CD14lineage). (F) Migration of CCR2þ monocytes and DC
toward cell-free biopsy culture supernatants from the proximal and distal human colon. DC migration was also determined with
and without speciﬁc blockage of anti-CCL2 in the culture supernatants. Results from the transwell experiments (E, F) are
displayed as the ratio of migrated cells compared with the basal migration (dotted line). Results from B and D are from at least
ﬁve independent experiments. Results from E summarize between three and six independent experiments per condition;
results from F summarize seven independent experiments. Paired t tests were applied, and P < .05 was considered statis-
tically signiﬁcant (*P < .05; **P < .01; ***P < .001; ****P < .0001).
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3 (ILT3),45 with no differences between CD103-SIRPaþ and
CD103þSIRPaþ DC; CD103þSIRPa DC were ILT3.
Conversely, ILT3 DC displayed a higher expression of the
costimulatory molecule CD40 (see Figure 2E).
Having characterized human colonic DC subsets, we next
determined whether proximal and distal human colonic DC
subsets had differences in activation/maturation andhoming marker expression. To this end, we examined
expression of CD40 (representative of DC maturation sta-
tus) and b7 (indicative of DC gut-homing capacity) on
different DC subsets. Given the low numbers of DC obtained
from human colonic biopsy samples (see Figure 1D), and
that SIRPa cells were scarce in all locations (see
Figures 2A–C), these markers were studied in
CD103þSIRPaþ and CD103-SIRPaþ DC subsets (analogous
Figure 3. (continued).
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respectively)9 to ensure measurable effects. Both subsets
from the proximal colon revealed lower b7 and higher CD40
expression compared with their distal counterparts (see
Figure 2F), suggesting that alterations in DC exist between
the proximal and distal compartments of human colon
irrespective of the DC subset.Chemokine (C-C Motif) Receptor 2 Mediates
Dendritic Cell Recruitment in the Colon
We next studied the potential mechanisms that may
account for blood DC recruitment by the human colon to see
whether there was a differential recruitment capacity eli-
cited by the proximal and distal sides. CCR2 mediates
monocyte recruitment in the intestinal mucosa, although its
expression may not be restricted to monocytes/macro-
phages as Scott et al20 have identiﬁed a novel CCR2þ DC
subset within murine and human intestinal DC. CCR2 was
expressed by most colonic CD103SIRPaþDC with expres-
sion being variable on CD103þSIRPaþ and absent on
CD103þSIRPa DC (Figure 3A), with no differences between
the proximal and distal side of the human colon (see
Figure 3B).
CCR2þ APC numbers are increased in the coeliac duo-
denum after in vivo gluten challenge,46 suggesting intestinal
recruitment of blood precursors. We therefore characterized
CCR2 expression on human circulating DC. Blood DC were
identiﬁed within HLA-DRþ cells (after exclusion of
CD14þCD16þCD19þ cells) and divided into subsets based
on the expression of CD123 (pDC), CD11c/CD1c (CD1cþ
mDC), and CD11c/CD141 (CD141þ mDC)5 (see Figure 3C).
Circulating CD1cþ mDC were SIRPaþILT3þCCR2þ in
contrast to circulating CD141þ mDC, which were
SIRPa-ILT3-CCR2 (see Figure 3D). Circulating CD1cþ mDC
therefore displayed a phenotype similar to intestinal SIRPaþ
DC (CD1cþILT3þCCR2þ) whereas circulating CD141þ mDC
had a phenotype similar to intestinal CD103þSIRPa DC
(CD141cþILT3-CCR2) (see Figures 2 and 3). These results
are in agreement with recent observations relating intesti-
nal SIRPaþ DC to circulating CD1cþ mDC and intestinal
CD103þSIRPa DC to circulating CD141þ mDC.9
The similar phenotype of intestinal SIRPaþ DC and circu-
lating CD1cþ mDC, and the expression of CCR2 on both DC
subsets suggest that they might be recruited to the colonic
mucosa in a CCR2-dependent manner. To explore this possi-
bility, we ﬁrst conﬁrmed that CCR2 on circulating mDC was
functional; these cells (togetherwithmonocytes)migrated in a
dose-dependent manner toward CCL2 in transwell migration
assays (see Figure 3E). Finally, we studied whether cell-free
colonic culture supernatants attracted circulating mDC.
Although circulating monocytes were not attracted by the
colonic culture supernatants, DC had a higher migration
(compared with the basal) toward distal (P ¼ .04) and prox-
imal (P ¼ .06) cell-free culture supernatants; migration was
CCR2 dependent as migration was reduced if the culture su-
pernatants had been previously blocked with anti-CCL2 (see
Figure 3F). These results conﬁrm that CCR2 expression is
functional on circulating mDC and that it mediates blood DCrecruitment by the human colon. However, there was no dif-
ferential capacity of the proximal and distal sides of the colon
to recruit circulating DC.
Proximal Colon Dendritic Cells Are More Mature
and Have Lower Homing Marker Expression
Given that there was not a differential capacity to recruit
circulating DC by the proximal or distal human colon (see
Figure 3), and that DC differences between the proximal and
distal compartments occurred in all DC subsets (see
Figure 2F), we next characterized in more detail the
phenotype and function of total mDC in each compartment.
As human proximal and distal colon DC expressed
different levels of b7 (see Figure 2F), we further studied the
expression and potential function of gut-homing molecules
b7 and CCR917,31 by DC isolated from the proximal
compared with the distal colon. MadCam1 (a4b7 ligand)
expression was equally distributed throughout the proximal
and distal colon although both e-cadherin (aEb7 ligand) and
CCL25 (CCR9 ligand) mRNA expression were lower in
proximal colon DC (Figure 4A). Fitting with the expression
patterns of their corresponding ligands, b7 and CCR9
expression were lower among DC from the proximal colon,
with the skin- and mucosal-homing cutaneous lymphocyte
antigen (CLA) and CCR10 molecules being absent (see
Figure 4B).
We next determined whether proximal/distal colonic
DC had a different maturational status, as suggested by
higher CD40 expression displayed by proximal colon DC
(see Figure 2F). DC in the proximal colon showed higher
expression of CD40, CD80, and CD86 and lower endocytic
capacity as assessed by uptake of FITC-dextran dye, sug-
gesting greater maturity (see Figure 4C). Lamina propria
DC were also studied by electron microscopy to further
analyze their maturation status as previously re-
ported.21,35 There was a higher proportion of mature DC in
the proximal colon as identiﬁed by their longer veils/
dendrites relative to their size and euchromatic nuclei (see
Figure 4D).35
Proximal Colonic Dendritic Cells Are More
Stimulatory With Lower Gut-Homing
Imprinting Capacity
Having described differences in the subsets and pheno-
type of proximal and distal colonic DC, we next studied
whether these differences were reﬂected functionally.
Colonic DC were enriched21,31,33 and cocultured with pre-
sorted CFSE-labeled allogeneic CD4þCD45RAþ T cells in a
mixed leucocyte reaction (Figure 5A). Compared with blood
DC, colonic DC display a low stimulatory capacity for naive
CD4þ T cells,31 which was dose dependent. However, the
distal colon DC stimulatory capacity was even lower than
that of their proximal counterparts (see Figure 5A), corre-
lating with their lower levels of maturation markers (see
Figure 4C). Proximal DC induced a greater proportion of
stimulated T cells to produce IL-17A, with no alterations in
production of other measured cytokines (see Figure 5B).
In agreement with lower homing marker/ligand expression
Figure 4. Proximal colon dendritic cells (DC) have lower homing marker expression and are more mature. (A) The
expression of mRNA of the gut-homing ligands MADCAM1, e-cadherin, and CCL25 was determined on noncultured biopsy
tissues by quantitative reverse-transcription polymerase chain reaction, with the results displayed in arbitrary units (U). (B) DC
from the proximal (Prox) and distal (Dist) human colon were identiﬁed (as in Figure 1A), and the expression of b7, cutaneous
lymphocyte antigen (CLA), CCR9, and CCR10 were determined by ﬂow cytometry. (C) Expression of costimulatory molecules
(CD40, CD80, CD86) and ﬂuorescein isothiocyanate–dextran endocytic capacity was also determined by ﬂow cytometry. (D)
Lamina propria dendritic cells were identiﬁed by electron microscopy in distal (Dist) and proximal (Prox) human colon biopsy
samples. DC were characterized as immature and mature according to heterocromatic/euromatic nuclei and veil/dendrite
extension. The percentage of mature DC is referred to the total number of studied DC in the proximal and distal colon. For the
ﬂow cytometry experiments (B, C), regions were set according to isotype controls (not shown). Histograms show paired
results from several independent experiments. Paired t tests were applied, and P < .05 was considered statistically signiﬁcant
(*P < .05; **P < .01; ***P < .01).
January 2016 CCR2 and Human Colonic DC 33in the proximal colon (see Figures 4A and B), proximal
DC had lower GI-tract homing (b7 and CCR9) and higher
non–GI-tract homing (cutaneous lymphocyte antigen [CLA]
and CCR4) imprinting capacity for stimulated T cells (see
Figure 5C). Thus, DC homing imprinting capacity may be not
only tissue but also subtissue speciﬁc.
Differences in the Proximal and Distal Colonic
Microenvironments
Finally, we studied potential mechanisms that may ac-
count for differences between proximal and distal colon DC.
Given that there was no differential capacity elicited by the
proximal or distal human colon to recruit circulating DC
(see Figure 3F), we next studied baseline levels of pro-
duction of soluble immune mediators after in vitro culture
of colonic biopsies. The proximal samples producedsigniﬁcantly larger amounts of IL-6, IL-22, IL-23, IL-27,
leptin (Figure 6A), and IgA (see Figure 6B). The proximal
colon also had lower levels of RALDH2 mRNA expression
(see Figure 6C).
We also studied the colonic microbiota, as its activity is
known to change through the length of the human GI
tract.6,47 We found that the overall mucosa-associated
microbiota load was higher in the distal colon (see
Figure 6D) although 16S rRNA gene sequencing analysis
revealed no differences in mucosa-associated microbiota
composition between the proximal and distal colonic
mucosae (see Figure 6E). Mean Shannon Diversity Index
scores, parsimony, and AMOVA tests comparing overall di-
versity and bacterial community structures between prox-
imal/distal colon showed no signiﬁcant differences, and
there were no operational taxonomic units (OTUs) or
Figure 4. (continued).
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gions. Interindividual variation was the greatest driver of
microbiota clustering patterns (see Figure 6E). These results
are consistent with many previous studies describing the
predominant mucosa-associated bacterial community as
host speciﬁc and uniformly distributed along the colon
while being signiﬁcantly different from the fecal/luminal
community.48,49Discussion
Here, we report that human DC subsets, phenotype, and
function differed between the proximal (right or ascending)
and distal (left or descending) ends of the colon. Our results
revealed that the proximal colon contained higher numbers
of DC, which were immunologically more active. Thus, DC of
the proximal colon showed a speciﬁc reduction of
CD103þSIRPaþ DC and were typically more mature, withhigher stimulatory capacity for T cells. However, balancing
this increased stimulatory capacity, they had a lower po-
tential to focus immune activity back to the colon, with
lower expression of GI-tract homing markers b7 and CCR9,
lower mRNA tissue expression of their ligands, and lower
imprinting capacity of these markers on T cells they stim-
ulate. Our results also revealed that intestinal CD103þ/
SIRPaþ DC were similar to circulating CD1cþmDC9 and may
enter the colonic mucosa in a CCR2-dependent manner.
Human colon DC were divided into different subsets
based on expression of CD103 and SIRPa, with the latter
recently redeﬁned as human analogs of murine CD11b.9,21
Although murine CD103CD11bþ DC can express interme-
diate levels of CX3CR1 (although less than in M4), CX3CR1
was absent in all human colon DC (Figure 2E).17 CD103 (aE)
was coexpressed with b7 on DC (Figure 2E), with their
abundance being reduced in the proximal colon, in agree-
ment with the lower e-cadherin mRNA expression (ligand
Figure 5. Proximal colon dendritic cells (DC) are more stimulatory with lower gut-homing imprinting capacity than
distal counterparts. (A) After 400,000 CFSE-labeled allogeneic CD4þCD45RAþ T-cells were cultured with different numbers
of paired proximal (Prox) and distal (Dist) human colonic DC, their stimulatory capacity was assessed as the percentage of
proliferating T-cells (CD3þCFSElow) by ﬂow cytometry. (B) Cytokine and (C) homing receptor proﬁle of resting (nonstimulated)
and dividing T cells (CD3þCFSElow) stimulated with 3% Prox/Dist colonic DC. Paired two-way analysis of variance (A) and
paired t tests (B, C) were applied. P < .05 was considered statistically signiﬁcant (*P < .05; **P < .01). Dot-plots are repre-
sentative of eight independent experiments displayed in the graphics as the mean ± standard error.
January 2016 CCR2 and Human Colonic DC 35for CD103þb7þ) (see Figure 4A) in that compartment. Dif-
ferential CD103þ DC distribution may account for differ-
ences in colonic DC function as murine CD103 DC have
increased IL-17 priming capacity,15 as seen here among
proximal human colonic DC (Figure 5B). SIRPa was equally
expressed on proximal and distal colon DC, rendering the
proximal colon with a speciﬁc reduction of CD103þSIRPaþ.
Further analysis conﬁrmed that colonic CD103þSIRPaþ and
CD103-SIRPaþ DC are CD1cþ whereas CD103þSIRPa are
mainly CD141þ, in agreement with recent observations
relating intestinal SIRPaþ (both CD103þ and CD103) to
blood CD1cþ mDC and intestinal CD103þSIRPa to blood
CD141þ mDC.9,10 Indeed, both circulating CD1cþ mDC and
intestinal SIRPaþ were CD1cþSIRPaþILT3þCCR2þ whereas
circulating CD141þ mDC and intestinal CD103þSIRPa
were CD141cþSIRPa-ILT3CCR2 (see Figures 2 and 3).Moreover, circulating CD1cþ mDC were recruited by
human colonic culture supernatants in a CCR2-dependent
manner (see Figure 3F). Given that DC are thought to ac-
quire CD103 once they have entered the mucosa10 in a
RALDH2-dependent manner,50 it may be possible that
circulating CD1cþ mDC enter the mucosa as CD103SIRPaþ
DC via CCR2 and subsequently acquire CD103 at the time
that they lose CCR2, thus explaining its variable expression
on CD103þSIRPaþ DC (see Figure 3A and B). The lower
expression of intestinal RALDH2 found in the proximal co-
lon (see Figure 6C) may also explain the lower proportion of
CD103þ DC in that compartment (see Figure 2B and C). The
additional mechanisms responsible, however, for circulating
CD141þ mDC recruitment by the human colon remain
elusive, as they do not express CCR2; it is likely that other
chemokine receptors may be involved in their recruitment.
Figure 6. Differences in the proximal and distal colonic microenvironments. (A) Fresh paired biopsies samples from the
distal (Dist) and proximal (Prox) human colon were cultured for 24 hours in complete medium and the cell-free culture su-
pernatants assessed for soluble cytokines/adipokines by Multiplex and (B) IgA content by radial immunodiffusion. (C) RALDH2
mRNA expression was determined on noncultured biopsy tissues by quantitative reverse-transcription polymerase chain
reaction (qRT-PCR), with the results displayed in arbitrary units (U). (D) Microbiota load, as measured by 16S rRNA quantity,
was determined on noncultured biopsy tissues from the proximal (Prox) and distal (Dist) human colon by qRT-PCR, with
the results displayed in arbitrary units (U). Paired t tests were applied, and P < .05 was considered statistically signiﬁcant
(*P < .05). (E) Cluster dendrogram, generated using the Bray Curtis calculator, displaying mucosal-associated microbiota
compositional proﬁles in the human colonic biopsy tissues. Each pair of samples clusters together in the dendrogram,
illustrating the large degree of interindividual variation rather than a signature proximal versus distal colonic bacterial proﬁle.
Bacterial families coloured in brown/yellow/orange represent the Bacteroidetes phylum, blue/grey the Firmicutes phylum, red/
purple the Proteobacteria phylum, and green the Actinobacteria phylum. (A–D) Paired t tests, with P < .05 was considered
statistically signiﬁcant (*P < .05; **P < .01; ***P < .001; ****P < .0001). Results from A–D are displayed as mean ± standard
error of 12 independent experiments.
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were restricted to a fraction of CD103SIRPaþ DC (both
human and murine), with its expression being absent on the
other intestinal subsets. However, we found that CCR2 was
expressed by all CD103-SIRPaþ, with expression being
variable on CD103þSIRPaþ and absent on CD103þSIRPa
DC. Further experiments conﬁrmed these results using
different CCR2 antibodies (Supplementary Figure 1),
potentially eliminating a technical issue. One of the reasons
for this discrepancy might be that Scott et al20 originally
described CCR2þCD103SIRPaþ DC in murine cells and
conﬁrmed their presence in human samples using tissue
resections from patients with colorectal cancer. In contrast,
in this study we used colonic biopsy samples from healthy
intestines. Despite providing limited material, this use of
normal tissue mitigates the abnormal effects of disease and
treatment that are inherent when using resected tissue,
typically derived from patients with acute GI cancer, in-
ﬂammatory bowel diseases, and/or related diseases. All oursamples were obtained from patients referred to clinics for
changes in bowel transit, rectal bleeding, and/or screening
for GI diseases, although in all cases they had normal tissue
structure which was thus considered to provide normal,
healthy colonic samples. Comparisons between healthy bi-
opsy tissues and cancer resections would be required to test
whether these differences in tissue source are the reason for
different results.
DC acquire a “tolerogenic” proﬁle after exposure to sol-
uble factors derived from intestinal epithelial cells,50 and
the proinﬂammatory milieu in inﬂammatory bowel disease
may abrogate their function.32,51 The proximal colon pro-
duced signiﬁcantly larger amounts of soluble immune me-
diators (see Figures 6A and B), which may be responsible, at
least to some extent, for the higher maturation status of
proximal DC. RALDH2 promotes conversion of dietary
vitamin A into retinoic acid, which mediates several of the
tolerogenic properties of GI DC, including their capacity to
generate Tregs and induce GI-tract homing markers on
Figure 6. (continued).
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was lower in the proximal colon (see Figure 6C), and that
retinoic acid mediates acquisition of GI-tract homing
markers on immune cells, this may also account for the
lower expression of GI-tract homing markers on DC and
their lower imprinting capacity on T cells they stimulate.
Lower GI-tract homing expression/imprinting capacity of
proximal DC is also coupled with lower mRNA tissue
expression of their ligands in the proximal colon (see
Figure 4A). Therefore, it may be possible that the proximal
and distal ends of the colon may use different levels of
homing marker/ligand molecules to ensure compartmen-
talization of immune responses.
In addition to the differences in the cytokine milieu
between the proximal and distal human colon, a differen-
tial modulatory effect of the colonic microbiota on intes-
tinal DC may contribute. Indeed, the mucosa-associated
microbiota load was lower in the proximal colon (see
Figure 6D).47 Despite the similarity in mucosal microbiota
composition between the proximal and distal colon (see
Figure 6E), in agreement with other observations,48,49 the
metabolic output of the microbiota changes through the
length of the GI tract as dietary compounds are gradually
depleted by the microbiota as they pass through the co-
lon.26 Therefore, the proximal and distal colonic microbiota
produce different levels of short-chain fatty acids52,53 and/or other extracellular molecular effectors,54 which may
modulate DC properties and/or mucosal production of
immune mediators (see Figures 6A–C). Indeed, we have
shown that, similar to the human proximal/distal differ-
ences reported here, the frequency of DC was higher in the
proximal colon of conventionally raised mice, with no dif-
ferences between proximal and distal compartments in
germ-free animals (Supplementary Figure 2; See
Supplementary Materials and Methods for further details
on the experiment). Therefore, regional DC differences
throughout the colon might not only be inﬂuenced by the
cytokine milieu itself but also directly or indirectly by
members of the microbiota.
In summary, our data suggest that human blood CD1cþ
mDC are recruited by the colonic mucosa in a CCR2-
dependent manner and conﬁrm that DC subsets, pheno-
type, and function are different between the proximal and
distal human colon, and reveal the proximal colon DC as
potentially more immunologically active than their distal
counterparts. Studies of the immune system of the GI tract
need therefore to take into account the immune compart-
mentalization throughout its length. Future studies will
address whether GI-tract DC compartmentalization con-
tributes to diseases such as subtypes of inﬂammatory
bowel diseases and/or colorectal cancer where disease is
anatomically restricted to different GI locations.
38 Bernardo et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 1Differences in disease incidence and severity could there-
fore be related to the varying immune activity of different
GI regions.References
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Supplementary Materials and Methods
Murine Experiments
Conventionally raised and germ-free (reared from germ-
free breeding pairs) male C57BL/6 mice were sacriﬁced at
8 weeks of age, and lamina propria cells were isolated for
ﬂow cytometry analysis. Brieﬂy; proximal and distal large
intestine was chopped into small pieces and incubated with
vigorous stirring (200 rpm) in complete media with 2 mM
EDTA for 15 minutes at 37C. This was repeated, then colon
pieces were recovered and incubated for 40 minutes at
37C with collagenase (type VIII, 100 U/mL; Sigma-Aldrich).
The lamina propria cells were then ﬁltered, washed, and
stained for ﬂow cytometry analysis on a BD Fortessa in-
strument (BD Biosciences, Oxford, United Kingdom) and
FlowJo software (Treestar, Ashland, OR). Antibodies used
were CD45 (clone 20-F11; BioLegend, San Diego, CA),
MHCII (clone 2G9; BD Biosciences), and CD11c (clone N418;
eBioscience, Wien, Austria). Staining was performed at 4C
in the presence of Fc receptor block (anti-CD16/32, clone
93; BioLegend). Zombie AQUA (BioLegend) was used for
live-dead discrimination according to manufacturer’s di-
rections. All experiments were performed with United
Kingdom Home Ofﬁce approval.
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Supplementary Figure 1. Dendritic cells (DC) were identiﬁed as in Figure 1A and divided into subsets based on
expression of CD103 and SIRPa. Chemokine (C-C motif) receptor 2 (CCR2) expression was determined in each DC subset
using two different clones labeled with different ﬂuorochromes: (A) clone 48607 labeled in Alexa 647 and (B) clone K036C2
labeled in PE-Cy7. The results are representative of two independent experiments performed with similar results.
Supplementary Figure 2. Dendritic cell (DC) compart-
mentalization in the murine colon is modulated by the
microbiota. DC from proximal (Prox) and distal (Dist) regions
of the colon in conventional (Conv) and germ-free (GF) mice
were identiﬁed by ﬂow cytometry within single colonic viable
cells (ZombieAQUACD45þ) and mean frequencies (with
standard deviation) displayed. The results are representative
of two independent experiments (n ¼ 5 mice per group in
each experiment). One-way analysis of variance with Tukey’s
multiple comparisons was applied, and P < .05 was
considered statistically signiﬁcant (*P < .05, pair-wise com-
parisons without an asterisk were not statistically signiﬁcant).
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Supplementary Table 1.Antibodies and Flow Cytometry
Antibody
Speciﬁcity Clone Conjugate Manufacturer
b7 FIB504 PE BD Biosciences
CCR2 K036C2 PE-Cy7 BioLegend
K036C2 APC BioLegend
48607 Alexa 647 BD Biosciences
CCR4 205410 APC R&D Systems
CCR7 150503 PE R&D Systems
CCR8 191704 APC R&D Systems
CCR9 248621 PE R&D Systems
CCR10 314305 APC R&D Systems
CD1c (BDCA1) AD5–8E7 FITC Miltenyi Biotech
AD5–8E7 PE Miltenyi Biotech
L161 Alexa700 BioLegend
CD3 UCHT1 PE-Cy5 BD Biosciences
CD11c KB90 FITC Dako
B-Ly6 PE BD Biosciences
3.9 PE-Cy7 eBioscience
B-Ly6 BV605 BD Biosciences
Bu15 APC-Cy7 BioLegend
CD14 M5E2 PE BD Biosciences
TÜK4 PE-Cy5 AbD Serotec
MFP9 PE-CF594 BD Biosciences
CD16 3G8 PE-Cy5 BD Biosciences
CD19 HIB19 PE-Cy5 BD Biosciences
CD34 581 PE-Cy5 BD Biosciences
CD40 LOB7/6 FITC BD Biosciences
LOB7/6 PE BD Biosciences
CD45 HI30 PE-Cy7 BD Biosciences
VS143 APC-Cy7 BioLegend
HI30 PE-Cy7 BioLegend
HI30 BUV395 BD Biosciences
CD64 10.1 PE-Cy5 Abcam
10.1 PE-Cy7 BioLegend
CD80 L307.4 FITC BD Biosciences
L307.4 PE BD Biosciences
CD86 BU63 FITC AbD Serotec
CD103 Ber-ACT8 FITC BD Biosciences
Ber-ACT8 PE BioLegend
Ber-ACT8 BV421 BD Biosciences
Ber-ACT8 PE-Cy7 BioLegend
CD123 6H6 PE-Cy7 eBioscience
7G3 BV786 BD Biosciences
CD141 (BDCA3) 501733 FITC R&D Systems
1A4 BV711 BD Biosciences
AD5–14H12 PE Miltenyi Biotech
CD172a (SIRPa) 602411 FITC R&D Systems
602411 PE R&D Systems
SE5A5 PE-Cy7 BioLegend
CD209 (DC-SIGN) 120507 FITC R&D Systems
120507 PE R&D Systems
Supplementary Table 1.Continued
Antibody
Speciﬁcity Clone Conjugate Manufacturer
CD303 (BDCA2) AC144 FITC Miltenyi Biotech
CLA HECA-452 APC BD Biosciences
HECA-452 Biotin BD Biosciences
CX3CR1 528728 PE R&D Systems
HLA-DR G46–6 APC R&D Systems
L243 BV570 BioLegend
IFNg 25723.11 APC BD Biosciences
IL-4 8DA-8 PE-Cy7 eBioscience
IL-6 AS12 FITC eBioscience
1936 PE R&D Systems
IL-10 BT-10 FITC eBioscience
JES3–9D7 PE-Cy7 eBioscience
JES3–19F1 APC BD Biosciences
IL-17A eBIO64DEC17 APC eBioscience
IL-22 22URTI APC eBioscience
IL22JOP PE-Cy7 eBioscience
ILT3 293623 PE R&D Systems
Streptavidin not applied APC BD Biosciences
TGFb 35409 PE R&D Systems
TLR2 TLR2.3 FITC AbD Serotec
TLR4 HTA125 FITC AbD Serotec
TNFa B-D9 FITC AbD Serotec
Mab11 PE-Cy7 eBioscience
Note: AbD Serotec, Kidlington, United Kingdom; BD Bio-
sciences, Oxford, United Kingdom; BioLegend, San Diego,
CA; Dako, Glostrup, Denmark; eBioscience, Wien, Austria;
Miltenyi Biotech, Bisley, United Kingdom; R&D Systems,
Minneapolis, MN.
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Supplementary Table 2.Quantitative Polymerase Chain Reaction Primers
Molecule Primers Sequence Ta Primer Source
GADPH
Forward 50-GAAGGTGAAGGTCGGAGTC-30 60 Ren et al, 2005
Reverse 50-GAAGATGGTGATGGGATTTC-30
16S rRNA
Forward 50-TTAAACTCAAAGGAATTGACGG-30 68 Ozbek et al, 2009
Reverse 50-CTCACGRCACGAGCTGACGAC-30
RALDH2 5532957001_Roche 60 Roche Diagnostics
CCL25
Forward 50-GATAAAACCGTCGCCCTACA-30 58 NCBI Reference Sequence: NM_005624.3
Reverse 50-TCCTTTGGGTCTGCACATAGC-30
MADCAM1
Forward 50-CTGTACGGCCCACAAAGTCA-30 60 NCBI Reference Sequence: NM_130760.2
Reverse 50-TCTGTCACCCTGAACAGCAC-30
e-cadherin
Forward 50-CAGTCTCTTCTCTCACGCGT-30 60 NCBI Reference Sequence: NM_004360.3
Reverse 50-TGAGGATGGTGTAAGCGATGG-30
Note: Primers used for quantitative polymerase chain reaction, including primer sequence or source and annealing temper-
ature (Ta). Primers for CCL25, MADCAM1, and e-cadherin were designed with Primer-BLAST (http://www.ncbi.nlm.nih.gov/
tools/primer-blast/) using the reference sequences provided in the table.
Sources: Ren M, Pozzi S, Bistulﬁ G, et al. Impaired retinoic acid (RA) signal leads to RARb2 epigenetic silencing and RA
resistance. Mol Cell Biol 2005;25:10591–10603; Ozbek SM, Ozbek A, Erdorgan AS. Analysis of Enterococcus faecalis in
samples from Turkish patients with primary endodontic infections and failed endodontic treatment by real-time PCR SYBR
green method. J Appl Oral Sci 2009;17:370–374; Ye J, Coulouris G, Zaretskaya I, et al. Primer-BLAST: a tool to design target-
speciﬁc primers for polymerase chain reaction. BMC Bioinformatics 2012;13:134.
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Supplementary Table 3.European Nucleotide Archive (ENA)
Accession Number Information for
Each of the Biopsy Tissue Sample
Sequencing Results From the
Microbiota Analyses
Sample
Name Biopsy Sample Info
ENA Sample
Accession No.
4L Patient 4, distal colon ERS557964
4R Patient 4, proximal colon ERS557965
9L Patient 9, distal colon ERS557966
9R Patient 9, proximal colon ERS557967
10L Patient 10, distal colon ERS557968
10R Patient 10, proximal colon ERS557969
11L Patient 11, distal colon ERS557970
11R Patient 11, proximal colon ERS557971
12L Patient 12, distal colon ERS557972
12R Patient 12, proximal colon ERS557973
14L Patient 14, distal colon ERS557974
14R Patient 14, proximal colon ERS557975
15L Patient 15, distal colon ERS557976
15R Patient 15, proximal colon ERS557977
16L Patient 16, distal colon ERS557978
16R Patient 16, proximal colon ERS557979
17L Patient 17, distal colon ERS557980
17R Patient 17, proximal colon ERS557981
18L Patient 18, distal colon ERS557982
18R Patient 18, proximal colon ERS557983
19L Patient 19, distal colon ERS557984
19R Patient 19, proximal colon ERS557985
23L Patient 23, distal colon ERS557986
23R Patient 23, proximal colon ERS557987
24L Patient 24, distal colon ERS557988
24R Patient 24, proximal colon ERS557989
25L Patient 25, distal colon ERS557990
25R Patient 25, proximal colon ERS557991
28L Patient 28, distal colon ERS557992
28R Patient 28, proximal colon ERS557993
29L Patient 29, distal colon ERS557994
29R Patient 29, proximal colon ERS557995
30L Patient 30, distal colon ERS557996
30R Patient 30, proximal colon ERS557997
31L Patient 31, distal colon ERS557998
31R Patient 31, proximal colon ERS557999
32L Patient 32, distal colon ERS558000
32R Patient 32, proximal colon ERS558001
Note: Samples marked L are from the left or distal colon;
those marked R are from the right or proximal colon. Euro-
pean Nucleotide Archive (http://www.ebi.ac.uk/ena).
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